UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The ...

OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...

MELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) -- CLINUVEL today announced that it is advancing new sustained-release liquid drug formulations in a preclinical program evaluating various drug ...

LONDON--(BUSINESS WIRE)--Global procurement intelligence advisory firm, SpendEdge, has announced the release of their ‘Pharmaceutical Formulation Equipment Procurement Research Report.’ The insights ...

Edison-based Pharmaceutical Formulations (OTC: PHFR) on Tuesday announced measures directed toward a recapitalization that would convert a significant portion of its current debt to equity. In a ...

This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions ...

Pharmaceutical Formulations said on Wednesday it is exploring a recapitalization plan that could include a rights offering to existing shareholders. The Edison-based maker of over-the-counter generic ...

Greenville, NC, October 09, 2010 --(PR.com)-- Joseph E. "Joe" Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional TM ...

Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported in Q3 CY2025, but sales were flat year on year at $191 ...

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for all four formulations of Gobivaz - Alvotech ...

During the quarter, the revenues of the company that operates in a single segment i.e. generic formulation business rose 14% ...

Sun Pharma’s Q2 revenue rose as innovative US drug sales exceeded generics. Domestic growth remained strong with new launches ...